Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection Published by American Society for Microbiology on August 9, 2022 Interested in more tuberculosis...
Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV Coinfection Published by ACS Infectious Diseases on June 30, 2022 Tuberculosis is a leading infectious disease and cause of death. Folks with HIV are...
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study Published by The Lancet Rheumatology on August 16, 2022 Biostatistics research professor Dr....
A 'Tripledemic'? Flu, R.S.V. and COVID May Collide This Winter, Experts Day Published by The New York Times on October 23, 2022 “Most of the time [the flu] doesn’t make you very sick, but sometimes it can,” said MCIDT Director and Associate Professor of Epidemiology,...
Why the Spectral Radius? An intuition-building introduction to the basic reproduction number Published by Springer on August 5, 2022 Dr. Andrew Brouwer of the University of Michigan Epidemiology Department explains the math behind the next generation method, why it...
Conference Travel Funding Available Through MCIDT The Michigan Center for Infectious Disease Threats is pleased to announce the launching of our Conference Travel Grant Program. Through this program, funding may be made available to graduate students or postdoctoral...
As researchers around the world continue to combat the COVID-19 pandemic, most agree on one issue: If history is any indication, there’s another pandemic coming.
From LSA Magazine, Summer 2022 At the Museums of Zoology and Paleontology, LSA researchers and undergraduates are busy digitizing scientific archives. What motivates them to transform fossils and specimens into 3-D models? Accessibility, education, and a little bit of...
In this pediatric cohort study, seropositivity was associated with 49-64% less symptomatic #COVID19 reinfection in Nicaragua, with variation across age groups. Symptomatic #SARSCoV2 reinfections were quite common, accounting for 20% of COVID-19 episodes.